Reata’s $275 Million Secured Term Loan Financing

Walder Wyss team advised the funds managed by Pharmakon Advisors, LP.Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a global pharmaceutical company primarily focused on investigating experimental oral antioxidative…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now